Device-related outcomes following hypoglossal nerve stimulator implantation
Journal of Clinical Sleep Medicine · 2024-09 · 20 (9) · 1497-1503
DOI: 10.5664/jcsm.11176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Sleep Medicine, 2024-09. Verfasst von Annie E Moroco und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Hypoglossal Nerve, Electric Stimulation Therapy, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
STUDY OBJECTIVES: Hypoglossal nerve stimulation (HGNS) has been widely used to treat obstructive sleep apnea in selected patients. Here we evaluate rates of revision and explant related to HGNS implantation and assess types of adverse events contributing to revision and explant. METHODS: Postmarket surveillance data for HGNS implanted between January 1, 2018 and March 31, 2022, were collected. Event rates and risk were calculated using the postmarket surveillance event counts and sales volume over the same period. Indications were categorized for analysis. Descriptive statistics were reported and freedom from explant or revision curves were grouped by year of implantation. RESULTS: Of the 20,881 HGNS implants assessed, rates of explant and revision within the first year were 0.723% and 1.542%, respectively. The most common indication for explant was infection (0.378%) and for revision was surgical correction (0.680%). Of the 5,820 devices with 3-year postimplantation data, the rate of explant was 2.680% and of revision was 3.557%. During this same interval, elective removal (1.478%) was the most common indication, and for revisions, surgical correction (1.134%). CONCLUSIONS: The efficacy of HGNS is comparable in the real world setting to published clinical trial data. Rates of explant and revision are low, supporting a satisfactory safety profile for this technology. CITATION: Moroco AE, Wei Z, Byrd I, et al. Device-related outcomes following hypoglossal nerve stimulator implantation. J Clin Sleep Med. 2024;20(9):1497-1503.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
- Department of Neurology and Jefferson Sleep Disorders Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
- Inspire Medical, Golden Valley, Minnesota.
- Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
- Department of Otolaryngology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
- Department of Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts.
Zitieren
APA
Moroco, A. E., Wei, Z., Byrd, I., Rasmussen, A., Chio, E. G., Soose, R. J., Huyett, P., Steffen, A., Heiser, C., Boon, M. S., & Huntley, C. T. (2024). Device-related outcomes following hypoglossal nerve stimulator implantation. Journal of Clinical Sleep Medicine, 20(9), 1497-1503. https://doi.org/10.5664/jcsm.11176
Vancouver
Moroco AE, Wei Z, Byrd I, Rasmussen A, Chio EG, Soose RJ, et al. Device-related outcomes following hypoglossal nerve stimulator implantation. Journal of Clinical Sleep Medicine. 2024;20(9):1497-1503. doi:10.5664/jcsm.11176
BibTeX
@article{Moroco2024,
author = {Moroco, Annie E and Wei, Zhikui and Byrd, Israel and Rasmussen, Andrea and Chio, Eugene G and Soose, Ryan J and Huyett, Phillip and Steffen, Armin and Heiser, Clemens and Boon, Maurits S and Huntley, Colin T},
title = {Device-related outcomes following hypoglossal nerve stimulator implantation},
journal = {Journal of Clinical Sleep Medicine},
year = {2024},
volume = {20},
number = {9},
pages = {1497--1503},
doi = {10.5664/jcsm.11176}
}
EUVIMED